Portfolio Thuja Capital Healthcare Fund I
Company: TheraSolve N.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2011
Status: Active
TheraSolve develops a skin patch technology (embedded electronics) to improve drug treatment compliance.
Company: Okapi Sciences N.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Active
Okapi develops antiviral drug products to treat viral diseases in pet animals and livestock.
Company: Bioceros B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized
Bioceros is active in the field of protein therapeutics, and offers producer cell line generation services; it also aims to develop an own therapeutic monoclonal antibody pipeline.
Company: arGEN-X B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Active
arGEN-X is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio.